Gain Therapeutics Announces Positive Results from the Single Ascending Dose Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Parkinsons Disease
TELLDelisted Stock | USD 1.00 0.00 0.00% |
About 54% of Tellurian's investor base is interested to short. The analysis of current outlook of investing in Tellurian suggests that many traders are impartial regarding Tellurian's prospects. Tellurian's investing sentiment shows overall attitude of investors towards Tellurian.
Tellurian |
BETHESDA, Md., April 24, 2024 -- Gain Therapeutics, Inc. , a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, announces positive results from the single ascending dose part of its Phase 1 study. GT-02287 was generally well tolerated up to and including the highest planned dose level, and there were no serious adverse events. The good safety and
Read at finance.yahoo.com
Tellurian Fundamental Analysis
We analyze Tellurian's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tellurian using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tellurian based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Asset
Current Asset Comparative Analysis
Tellurian is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Tellurian Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tellurian stock to make a market-neutral strategy. Peer analysis of Tellurian could also be used in its relative valuation, which is a method of valuing Tellurian by comparing valuation metrics with similar companies.
Peers
Tellurian Related Equities
CRK | Comstock Resources | 3.26 | ||||
KOS | Kosmos Energy | 2.21 | ||||
PED | PEDEVCO Corp | 1.28 | ||||
CTRA | Coterra Energy | 0.20 | ||||
PR | Permian Resources | 0.20 | ||||
RRC | Range Resources | 0.44 | ||||
AR | Antero Resources | 0.45 | ||||
EQT | EQT | 0.51 | ||||
EPSN | Epsilon Energy | 0.67 | ||||
COP | ConocoPhillips | 0.78 | ||||
DVN | Devon Energy | 2.20 | ||||
FANG | Diamondback Energy | 2.38 | ||||
GPRK | GeoPark | 2.58 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Tellurian Stock
If you are still planning to invest in Tellurian check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tellurian's history and understand the potential risks before investing.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |